Overview

Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.

Status:
Unknown status

Trial end date:
2005-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether transdermally administered 17-beta estradiol sequentially could reduce the number of, and severity of, menstrual migraine attacks.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University Hospital, Linkoeping

Treatments:

Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate